Previous studies showed that COX2 inhibitors, such as nonsteroidal anti-inflammatory drugs (NSAIDs), may decrease the risk and improve prognosis of carcinogenesis of various types of cancer including colorectal cancer [21,22,23,24]. The gene discussed is PTGS2; the disease is cancer.